Market Place
Sourcing Support
Abortion pill ruling offers measure of relief for FDA, biotech
17 Jun 2024 //
BIOPHARMADIVE
Teva sues Corcept over mifepristone `monopoly` for rare disorder
14 Jun 2024 //
REUTERS
US Supreme Court preserves access to abortion pill mifepristone
14 Jun 2024 //
REUTERS
Danco Laboratories, LLC comments on U.S. Supreme Court decision
13 Jun 2024 //
PR NEWSWIRE
US Supreme Court abortion pill fight brings claims of distorted science
25 Mar 2024 //
REUTERS
US lawyer urges Supreme Court to overturn mifepristone verdict
27 Nov 2023 //
FIERCE PHARMA
California sues organizations for touting abortion pill reversal
21 Sep 2023 //
REUTERS
Abortion pill maker loses bid to block West Virginia`s abortion ban
25 Aug 2023 //
REUTERS
DOJ plans to take mifepristone challenge to the Supreme Court
17 Aug 2023 //
ENDPTS
House Republicans use FDA appropriations bill to override REMS changes
16 Jun 2023 //
ENDPTS
Abortion pill maker seeks to keep challenge to W. Va. abortion ban alive
23 May 2023 //
REUTERS
Federal appeals court in New Orleans holds hearing on FDA-approved abortion pill
18 May 2023 //
FOX8LIVE
US appeals judges express support for opponents of abortion pill
17 May 2023 //
REUTERS
As US debates abortion pill ban, Argentina expands its use
16 May 2023 //
REUTERS
Abortion providers in 3 states sue over mifepristone restrictions
09 May 2023 //
BIOPHARMADIVE
Abortion providers sue FDA in federal court over mifepristone restrictions
09 May 2023 //
ENDPTS
Supreme Court pauses abortion pill restrictions from taking effect during appeal
25 Apr 2023 //
THEHILL
Supreme Court presses pause on mifepristone curbs
22 Apr 2023 //
PHARMAPHORUM
U.S. Supreme Court preserves broad access to abortion pill
22 Apr 2023 //
REUTERS
Supreme Court preserves access to abortion pill as court cases play out
21 Apr 2023 //
ENDPTS
Abortion pill can`t just `snap back` to pre-2016, FDA`s Woodcock tells SCOTUS
17 Apr 2023 //
ENDPTS
Abortion pill maker asks U.S. Supreme Court to stop curbs on access to drug
15 Apr 2023 //
REUTERS
Some U.S. abortion pill providers curb availability after appeals court ruling
13 Apr 2023 //
REUTERS
Abortion pill access may continue even if FDA loses US court battle
13 Apr 2023 //
REUTERS
FDA may need to `get creative` if abortion pill approval pulled this week
12 Apr 2023 //
ENDPTS
Abortion pill opponents urge US appeals court to allow ban
12 Apr 2023 //
REUTERS
Pfizer, Biogen among drugmakers calling for abortion pill ruling reversal
11 Apr 2023 //
REUTERS
Texas court ruling on abortion pill opens FDA & approval decisions to political attacks
10 Apr 2023 //
ENDPTS
In abortion pill litigation, 2 judges issue opposing rulings
10 Apr 2023 //
FIERCE PHARMA
White House plans support for drugstores, pharma in abortion pill battle
09 Apr 2023 //
REUTERS
Federal judge invalidates FDA approval of abortion pill
08 Apr 2023 //
BIOPHARMADIVE
US judge suspends approval of mifepristone in latest abortion setback
08 Apr 2023 //
REUTERS
Statement In Response To Texas Ruling Upending FDA Approval of Mifeprex
07 Apr 2023 //
PR NEWSWIRE
In US abortion pill case, FDA could soften blow of court-ordered restrictions
23 Mar 2023 //
REUTERS
Alzheimer`s Association lobbies for Medicare coverage of Leqembi and other drugs
16 Mar 2023 //
REUTERS
Walgreens Statement on Mifepristone
06 Mar 2023 //
BUSINESSWIRE
Democratic-led U.S. states challenge restrictions on abortion pill
24 Feb 2023 //
REUTERS
Law experts argue abortion drug withdrawal would `undermine` approval process
14 Feb 2023 //
ENDPTS
Abortion pill maker GenBioPro sues WV over abortion ban
27 Jan 2023 //
FIERCE PHARMA
Abortion pill maker GenBioPro sues WV over abortion ban
26 Jan 2023 //
FIERCE PHARMA
FDA fires back in lawsuit over abortion pill approval
18 Jan 2023 //
FIERCE PHARMA
Reversing abortion drug`s approval would harm public interest, U.S. FDA says
17 Jan 2023 //
REUTERS
Conservative group sues FDA for 2000 approval of abortion pill
22 Nov 2022 //
FIERCEPHARMA
State battles over mifepristone access could tie FDA to any post-Roe crossroads
27 Jun 2022 //
ENDPTS
House members urge FDA to remove in-person requirement for abortion medication
19 Aug 2021 //
THEHILL
FDA dispenses with in-person requirement for abortion pill access in pandemic
14 Apr 2021 //
ENDPTS
Easing Restrictions On The Abortion Pill Could Help Improve Access To Care
15 Sep 2020 //
FORBES
Politicizing Safety Of The Abortion Pill Mifeprex
08 Sep 2020 //
FORBES
Teva Pharms USA Generic Mifepristone Receives Approval in US
07 Aug 2020 //
FDA
WHO keeps key lung cancer drugs off its essential medicines list
10 Jul 2019 //
REUTERS
Summary Basis of Decision - Mifegymiso
17 Apr 2019 //
HPR-RPS
Teva Pharms USA`s Generic Mifepristone Receives Tentative Approval in US
19 Oct 2018 //
FDA
Drug combination better for restoring womb after miscarriage
07 Jun 2018 //
REUTERS
GAO Finds Mixed Views on FDA Monitoring of Abortion Pill
29 Mar 2018 //
RAPS
Korlym® (Mifepristone) : Corcept Therapeutics,v. Teva Pharmaceuticals USA
15 Mar 2018 //
PATENT LITIGATION
Corcept Plans Korlym Label Expansion, Pipeline in Progress
08 Mar 2018 //
NASDAQ
FDA Confirms Paragraph IV Patent Challenge of Korlym (Mifepristone) Tablets
15 Feb 2018 //
FDA
WHO`s Position on the Import Alert for a Chinese API Manufacturer`s Products
04 Jul 2017 //
GMP
Qinhuangdao Zizhu Pharmaceutical Co. Ltd On WHO Public Inspection Report
30 Jun 2017 //
WHO
US ban for levonorgestrel supplier Qinhuangdao Zizhu raises WHO concerns
20 Apr 2017 //
IN PHARMATECHNOLOGIST
